Breaking Tech News: SoundView Technology Group Issues NXT-ID (OTCQB: NXTD) Update Following Wocket Smart Wallet Launch Event

BOSTON - June 11, 2014 (Investorideas.com Newswire) We attended the NXT-ID (OTCQB: NXTD) Wocket(TM) smart wallet launch event in NYC on May 28th and were pleased with the number of features present in the device demonstrated and encouraged by early consumer reaction to the Wocket.

Just one week later we heard Rudy Giuliani talk about how cyber crime has reached "crisis proportions" because "all our sensitive data is in the cloud for criminals to access." His sentiment helps explain why a secure device like the Wocket will be a preferred solution for sensitive financial and other key data.
NXT-ID is offering pre-orders for the Wocket smart wallet (www.wocketwallet.com) at $149 and the first shipments to customers are planned for late September. After a review we are keeping our 2014 forecast of 40,000 units and will be evaluating consumer response in order to validate our longer term projects.
We're also introducing a longer term intrinsic value (IV) estimate of $20.55 for 2015. With a current IV estimate of $11.70 we think growth investors will find the risk/reward of this situation to be attractive.
We previously stated in a prior update, " We believe in the digital conversion of our "wallet" over time and know that mobile devices alone won't be the answer for many years due to power limits, lack of privacy and security concerns. Nobody knows if the NXT-ID Wocket is going to be "the one" but we do know that so far it's the most well designed product we have seen that is coming to market this year."
Our NXT research update (PDF) is available here: http://s3.amazonaws.com/Published_Research/NXT-ID_NXTD_Update_Note_Final_June_2014.pdf
COMPANY OVERVIEW
NXT-ID is an emerging technology company that is building an innovative, next generation information security platform using advanced biometric technology to enable secure transactions, identity management, and access control via mobile and other devices in an intuitive, cost-effective and easy-to-use manner. Led by CEO Gino Pereira and CTO David Tunnell, the company has three distinct lines of business: law enforcement, m-commerce, and biometric access control application.
"NXT-ID is creating a new paradigm for information security beyond the password that is based on innovative biometric technology."
Past reports and related research can be found on our website at http://soundview.co/infosec.
Disclosure: SoundView Technology Group is providing fee-based advisory services to NXT-ID on investment positioning, strategy and business development. Our research opinions are our own and based as much as possible on factual information and observations. Additional information about SoundView can be found at http://soundview.co.
Kris Tuttle
SoundView Technology Group
kris@soundview.co
+1-617-828-6462

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: As of June 2014, NXT-Id renewed for five thousand per month and average of two thousand five hundred 144 shares (cash equivalent) for news publication and marketing of Wocket smart wallet. More info: http://www.investorideas.com/About/Disclaimer.asp and http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Breaking Tech News: Offer to Purchase Limited Edition Wocket™ Smart Wallet to NXT-ID (OTCQB: NXTD) Shareholders Expires June 15th

SHELTON, Conn. - June 9, 2014 (Investorideas.com Newswire) NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused on the growing m-commerce market, reports the offer to purchase a limited edition, "Signature," Wocket smart wallet to shareholders, will expire on Monday, June 16th. Wocket™ is a next generation smart wallet, designed to replace all the cards in your wallet.

"The shareholder version will differentiate from the first consumer edition," said Mr, Gino Pereira, CEO of NXT-ID, Inc. "It will include a unique home button featuring the new corporate logo. The special button will be retired after this edition. And most importantly to collectors, it will be a numbered limited edition."
He went on to say, "To purchase the 'Signature' Wocket, one can simply visit the website (http://wocketwallet.com/) and check the drop-down box for the, 'Signature Edition (Shareholders Only)' option. We now accept all payment options, including: Visa, MasterCard, American Express and PayPal. We will confirm the shareholder position with our transfer agent and it will be shipped with the first product run estimated in September."
Wocket is currently priced at $149.99.
Shareholders of record owning 100 shares or more as of May 23rd, 2014 that advance order, and pay for, a Wocket on the website www.wocketwallet.com before the end of the day on June 15th, 2014 will be issued the special limited "Signature" edition Wocket.
NXT-ID is currently launching an online digital marketing campaign for its smart wallet, Wocket™. At the recent Plaza press conference in May, Mr. Gino Pereira stated this was in addition to the recent CNBC ads and part of an ongoing effort, "to make Wocket a household name."
Wocket™ is a smart wallet in the same vein as the smart phone and smart watch. NXT-ID is introducing its innovative, patent-pending Wocket™ as the next natural step in the evolution of smart devices. Wocket™ is a next generation smart wallet designed to protect your identity and replace all the cards in your wallet, with no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.
Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. More than 10,000 cards, records, coupons, etc. and 100 voice commands can also be stored on Wocket™.
Advance ordering is available at http://www.wocketwallet.com/
The Wocket product FAQ is available to consumers and media at http://nxt-id.com/wocket-faq/
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™ ; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.thewocket.com/, http://www.wocketwallet.com/
NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Corporate info: info@nxt-id.com
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
ksmith@proactivecapital.com
Media: 800 665-0411

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: As of June 2014, NXT-Id renewed for five thousand per month and average of two thousand five hundred 144 shares (cash equivalent) for news publication and marketing of Wocket smart wallet. More info: http://www.investorideas.com/About/Disclaimer.asp and http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Breaking Tech News: More Protection with NXT-ID's (OTCQB: NXTD) Wocket™ Smart Wallet; Securely Store All Your Passwords in Your Own Personal Vault

SHELTON, Conn. - June 10, 2014 (Investorideas.com Newswire) NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused on the growing mobile commerce market, revealed today its Wocket™ Smart Wallet will include a password storage feature, further demonstrating the versatility of Wocket™ to store and protect a wide range of private information. With this password list feature, Wocket™ owners can store and securely access all their login credentials such as usernames and passwords on a Wocket™ in addition to payment, loyalty, identity and other cards typically held within a wallet. Users will soon be able to utilize Wocket™ for secure, biometrically locked, password storage in lieu of similar online solutions where data is at risk.

"Passwords continue to be a difficult issue for consumers. 2013 was clearly the "Year of Personal Data Breach", with 110 million credit and debit card account numbers lost to hackers by Target alone," says David Tunnell, CTO of NXT-ID. "Heartbleed and other security vulnerabilities demonstrate the need for a new method for consumer's to protect their private data. Users all over the world utilize online password storage services to store thousands of passwords behind one master password. If a hacker were to gain access to that one master password, they would gain access to all the user's passwords. That is the root of the problem with online storage of private data."
Wocket™ enables users to store and encrypt their passwords locally, and securely inside their own smart wallet. Wocket™ owners will also be able to store other sensitive information such as Social Security Numbers and insurance cards on Wocket™ instead of online servers and applications where their identity is potentially vulnerable.
Wocket™ is a smart wallet in the same vein as the smart phone and smart watch. NXT-ID is introducing its innovative, patent-pending Wocket™ as the next natural step in the evolution of smart devices. Wocket™ is a next generation smart wallet designed to protect your identity and replace all the cards in your wallet, with no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.
Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. More than 10,000 cards, records, coupons, etc. and 100 voice commands can also be stored on Wocket™.
Advance ordering is available at http://www.wocketwallet.com/
The Wocket product FAQ is available to consumers and media at http://nxt-id.com/wocket-faq/
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™ ; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.thewocket.com/, http://www.wocketwallet.com/
NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, the Company's securities.
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Corporate info: info@nxt-id.com
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
ksmith@proactivecapital.com
Media: 800 665-0411

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: As of June 2014, NXT-Id renewed for five thousand per month and average of two thousand five hundred 144 shares (cash equivalent) for news publication and marketing of Wocket smart wallet. More info: http://www.investorideas.com/About/Disclaimer.asp and http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Medical Technology News: Medical Technology The Role of Aethlon Medical (OTCQB: AEMD) in the Emerging Immuno-Oncology Market; Q&A with Aethlon Chairman and CEO, Jim Joyce

Point Roberts, WA, NEW YORK, NY - June 10, 2014 (Investorideas.com newswire) Investorideas.com, a global news source covering leading sectors including biotech and medical technology issues a Q&A interview with Mr. James A. Joyce ,Chairman and CEO of Aethlon Medical, Inc. (OTCBB:AEMD).

Q: Investorideas.com
How did Aethlon Medical become involved in cancer research?
A: James A. Joyce, Chairman, CEO
Several years ago, we made a bet that particles known as exosomes, were released by tumors to suppress the immune system of cancer patients. We believed that exosomes triggered the death of the immune cells you need to combat cancer. That cancer deployed exosomes as a mechanism to survive and proliferate. It is important to recognize that when we initiated our exosome research programs, the medical community viewed these particles as nothing more than cellular debris with no biological function.
Our second bet was that our Hemopurifier, the same Hemopurifer that has been utilized in the treatment of HIV and hepatitis c infected individuals, could capture tumor-secreted exosomes underlying a wide range of cancers. As it turns out, we were right on both accounts. Exosomes suppress the immune system and can be captured by our Hemopurifier. As a result, we are positioned to address a significant unmet medical need in cancer care. However, to leverage our opportunity in cancer we needed a market for immune-based therapies to emerge. Fortunately, the growing interest in immune-based therapies has now triggered an Immuno-Oncology industry explosion.
Q:Investorideas.com
Can you describe the Immuno-Oncology industry?
A: James A. Joyce ,Chairman, CEO
The Immuno-Oncology industry is based on therapies that augment or train the immune system to better combat cancer. The long-term goal of the Immuno-Oncology industry is to eliminate the need for toxic chemotherapy and radiation in cancer care. In fact, I suspect mankind will someday look back in disbelief at the barbaric use of chemo and radiation. Regardless, huge bets are being made that Immuno-Oncology will revolutionize the cancer field. Analysts at Citigroup predict the Immuno-Oncology market, which basically didn't exist two years ago, will reach $35 billion per year. This prediction is further reinforced by the fact that Merck, Bristol-Myers, AstraZeneca and Roche alone have already initiated more than 78 immune-based clinical studies.
Q:Investorideas.com
What Immuno-Oncology role do you feel Aethlon Medical will play?
A: James A. Joyce ,Chairman, CEO
We believe Hemopurifier therapy should play a central role in the Immuno-Oncology marketplace. Especially if you consider that as a device, our Hemopurifier can be combined to improve the benefit of other therapies without adding drug toxicity. It's not hard to envision that the elimination of tumor-secreted exosomes from circulation would improve the ability for immune-based drugs to combat cancer. From a mechanistic standpoint, combining a drug that stimulates the immune response with a device that inhibits immune-suppression would seem to be the perfect therapeutic marriage.
Q:Investorideas.com
Why are tumor-secreted exosomes an important cancer therapy target?
A: James A. Joyce ,Chairman, CEO
Last month, researchers from Harvard, Massachusetts General and Oxford published an article that discussed why tumor-secreted exosomes are cancer therapy targets. The article referenced the current knowledge that exosomes promote cancer progression by suppressing the immune system. However, that's just the beginning as the researchers also pointed to evidence that exosomes trigger resistance to drug therapies, that they play a role in allowing tumors to create their own blood supply for survival, and that they are seeds that allow for the creation and spread of cancer metastasis. The article also validated another original belief of ours; that the level of tumor-secreted exosomes in circulation correlates with the stage of cancer progression. In other words, if you don't have cancer, tumor-secreted exosomes won't be present. However, if you have advanced-stage cancer, they will be present in massive quantities. Based on this knowledge, it’s possible that circulating exosome load will someday become an industry standard for monitoring cancer progression in much the same way circulating viral load is the standard for monitoring infectious disease progression. Regardless, the article only referenced one company with a therapeutic strategy to address tumor-secreted exosomes. That was Aethlon Medical. Oh, and by the way, the authors of the article were sponsored by the National Cancer Institute.
Q:Investorideas.com
Is there anything else about tumor-secreted exosomes that we should know?
A: James A. Joyce ,Chairman, CEO
Yes, tumor-secreted exosomes have been discovered to transport PD-1, which is perhaps the most important target of drug companies advancing immuno-oncology therapies. In fact, the latest scientific literature seems to suggest that exosomes may be providing a transport mechanism for many pharmaceutical industry targets as a means for them to proliferate below the surveillance of the immune system.
Q:Investorideas.com
Based on the opportunity in cancer care, are you moving away from the infectious disease market?
A: James A. Joyce ,Chairman, CEO
The rapidly emerging opportunity in cancer allows us to expand the utility of Hemopurifier therapy. It does not replace our infectious disease endeavors, which is evidenced by plans to launch the first FDA approved study of Hemopurifier therapy in hepatitis c (HCV) patients. We believe that drug resistance and viral mutation will continue to drive opportunities for us in the HIV and HCV space and we also recognize that the proven broad-spectrum capabilities of Hemopurifier therapy provides a backdrop to address viral pathogens that remain untreatable with drug or vaccine therapies. However, I won't be surprised if it’s our ability to capture tumor-secreted exosomes that drives broad awareness of Hemopurifier therapy among both the medical and investment community.
About Aethlon Medical .( OTCBB:AEMD ).and Jim Joyce:
Aethlon Medical creates therapeutic devices to address infectious disease, cancer and other life-threatening conditions. The Company's lead product is the Aethlon Hemopurifier®, an extracorporeal device that addresses a broad-spectrum of viral pathogens as well as tumor-secreted exosomes. Jim Joyce is the founder, Chairman and CEO of Aethlon Medical.
http://www.aethlonmedical.com/
About Investorideas.com ( www.investorideas.com )
InvestorIdeas.com is a global news source and research resource covering leading sectors including medical technology, biotech, defense, water, mining and energy.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Sign up for free news alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in leading sectors
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Disclosure: AEMD subscribes to the Investorideas newswire content publishing annual program ( 9700 per Year, paid quarterly) for news publishing .
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Contact Investorideas.com 800 665 041

Biotech News Alert: SUNSHINE BIOPHARMA'S (OTCQB: SBFM) Adva-27a FEATURED IN 2014 WORLDWIDE UTERINE CANCER REPORT FOR ITS EFFECTIVENESS AGAINST MULTIDRUG RESISTANT UTERINE CANCER CELLS

Montreal, Quebec, Canada - June 9, 2014 (Investorideas.com Biotech Newswire) Sunshine Biopharma, Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that Adva-27a, the Company’s flagship oncology drug candidate was featured in Global Markets Direct: Uterine Cancer - Pipeline Review, H1 2014 Report for its effectiveness against multidrug resistant uterine cancer cells in vitro.

The Global Markets Direct Uterine Cancer Report provides comprehensive information on the therapeutic development for Uterine Cancer, with comparative analysis, therapeutics assessment, mechanism of action, route of administration and molecule type.  The Report also reviews key players involved in the therapeutic development for Uterine Cancer including Sunshine Biopharma Inc.
In December 2012, Sunshine Biopharma announced that it had achieved dramatic effects in Uterine Cancer using its Adva-27a compound. The studies were carried out in MES-SA/Dx5, a Uterine Sarcoma cell line that has become multidrug resistant through the use of a commonly administered chemotherapy drug, Doxorubicin.  Adva-27a was able to efficiently kill these cells with an IC50 of less than 8 micromolar, a pharmacologically very favorable drug concentration.
In addition to Uterine Cancer, Adva-27a has been shown to be effective at killing multidrug resistant Breast Cancer cells, Small-Cell Lung Cancer cells and Pancreatic Cancer cells (Published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012).
Sunshine Biopharma recently reported that it has initiated the construction of mouse xenograft models for Pancreatic Cancer as part of the plans of positioning Adva-27a for clinical development for Pancreatic Cancer in parallel with the previously announced multidrug resistant Breast Cancer indication. The first U.S. patent covering Adva-27a was issued on August 7, 2012 under U.S. patent number 8,236,935.
"We are very pleased that this testing indicated that our drug, Adva-27a, is effective against Uterine Cancer," said Dr. Steve N. Slilaty, CEO of Sunshine Biopharma. "In the U.S. alone, over 52,000 new cases of Uterine Cancer are diagnosed each year. "We are anxious to begin our clinical studies soon and look forward to the opportunity of providing a new treatment for Uterine Cancer patients worldwide," he added.
About The Global Markets Direct: Uterine Cancer - Pipeline Review, H1 2014 Report
The following links provide more information about the Global Markets Direct: Uterine Cancer - Pipeline Review, H1 2014:
http://www.globalmarketsdirect.com/Report.aspx?ID=Uterine-Cancer-Pipeline-Review-H1-2014&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_and_Healthcare
http://www.researchandmarkets.com/research/9bk98l/uterinecancer
About Adva-27a
Adva-27a is Sunshine Biopharma's lead anticancer compound, a small molecule that has recently been shown to be effective at killing multidrug resistant Breast Cancer cells, Small-Cell Lung Cancer cells, Uterine Sarcoma cells and Pancreatic Cancer cells (Published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012). Adva-27a is currently in the IND-Enabling stage of development. The original U.S. patent covering Adva-27a was issued on August 7, 2012 under U.S. patent number 8,236,935. The Company is planning a Phase I clinical trial of Adva-27a for Pancreatic Cancer in parallel to the Phase I clinical trial of Adva-27a for multidrug resistant Breast Cancer to be conducted at McGill University's Jewish General Hospital in Montreal (Canada).
Safe Harbor Forward-Looking Statements
To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.
For Additional Information Contact:
Camille Sebaaly, CFO
Sunshine Biopharma Inc.
Direct Line: 514-814-0464
camille.sebaaly@sunshinebiopharma.com
www.sunshinebiopharma.com
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: SBFM has renewed effective December 3,2013 with Investorideas for six months of news publication and general public awareness of the company news and technologies and products in the biopharma markets ( one hundred thousand shares of 144 stock per 3 month period for a total of six months ) More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Tech News Alert: Security and Convenience in the Payment Industry; CEO's of Dwolla and NXT-ID's (OTCQB: NXTD) Wocket™ Share How They Plan to Revolutionize the Sector

New York, NY - Point Roberts, WA - June 5, 2014 (Investorideas.com Newswire) Investorideas.com, a global news source covering leading sectors including mobile payments and payment technologies, issues a report on emerging payment technology companies Dwolla and NXT-ID, Inc. Recently, InvestorIdeas attended both the Cartes Conference held in Las Vegas and the NXT-ID, Inc.( OTCQB: NXTD ) Wocket™ smart wallet press conference held at the Plaza Hotel in New York, gaining insight on how the CEO’s of the two companies are taking a very different approach towards solving the same problem; security in the payment industry.

The ongoing breaches that consumers and businesses are faced with daily, such as those that affected Target and eBay, have incited the birth of new technologies including mobile apps, internet and cloud solutions and new digital wallets.They are all looking to protect our identity and make our financial transactions secure .
CEO and Founder Ben Milne of Dwolla said at Cartes, “We set money free.”
The Company website says “We're not like those other big payment companies that rely on plastic cards and charge hefty fees. Instead, we’ve built our own network that securely connects to your bank account and allows you to move money for just $0.25 per transaction, or free for transactions $10 or less.”
At the Cartes conference he told a captive audience, “We literally took everything the card does and built it into a protocol and just replaced the card and with it a whole lot of problems go out the door. This is not a philosophical idea, this has actually been built and being distributed. We are currently integrated with governments, businesses and even banks. Some regulated entities and publicly traded companies utilize our network on a daily basis and it’s all without a card !”
So Dwolla aims to eliminate our plastic cards - while newcomer NXT-ID, Inc. wants to replace all the cards in your wallet (up to 10,000 if you have them) with one biometrically secure card and a Wocket™ smart wallet.
Mr. Gino Pereira, Chief Executive Officer of NXT-ID started his presentation at the Plaza by stating "Meet Wocket, the smartest wallet you will ever own."
“In the last 18 months there have been a billion breaches of private information. One in ten of us have had our identity stolen. What can we actually do about this? It turns out that 44% of identity fraud can be traced to a stolen wallet or purse. If we can do something about protecting the information in our wallets, then we can cut down tremendously on the incidents of identity fraud. That’s why you need a Wocket.”
He went on to explain, “You can store 10,000 pieces of information on here in your own personal vault, It can only be accessed by you, by your voice biometrically or with a PIN, or by drawing a shape on a screen. You can store all your loyalty cards, gift cards, credit cards, on a slim, easy to use device. We think this is the evolution of smart . You started with smart phones, you then had smart watches; this is a smart wallet.”
“When you select a card that you want to use on your Wocket touchscreen, it gets programmed on the Wocket card and you hand the Wocket card to your server or attendant and they will check you out just like with any other credit card. Bu it’s on one single card! For security, the information that is transferred onto the card is erased or zeroized a very short time after it is charged.”
He closed with “This is the Wocket™, it retails for $149.99 and it’s available at www.wocketwallet.com” , followed by a public demonstration of the first financial transaction with a Wocket™.
According to a recent report from Business Intelligence, “The credit card companies themselves aren’t going anywhere for now. Visa and MasterCard in particular will remain an indispensable part of the chain because they don’t actually process payments. They simply provide the rails that the credit card system runs on. Credit card processors like First Data that actually do the work of processing merchants’ credit card transactions on the back-end are also in a strong position.”
So what is the future of payments; one card, no card? “One thing we know is the way we do it today is not ideal”, said Ben Milne of Dwolla.
Mr. Gino Pereira, Chief Executive Officer of NXT-ID quoted well-known scientist Alan Kay during his presentation reminding us, “The best way to predict the future is to invent it.”
See the Videos:
Video Clip of CEO and Founder Ben Milne of Dwolla in Las Vegas May 14th, 2014:
http://www.youtube.com/watch?v=bDmZWxbrZHM

Video of Mr. Gino Pereira, Chief Executive Officer of NXT-ID at Plaza Hotel in New York City May 28 th
http://youtu.be/joOi60S6LCk

About Dwolla
Dwolla is a payment network that allows any business or person to send, request and accept money. We're not like those other big payment companies that rely on plastic cards and charge hefty fees. Instead, we’ve built our own network that securely connects to your bank account and allows you to move money for just $0.25 per transaction, or free for transactions $10 or less. https://www.dwolla.com/
About NXT-ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™ ; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.wocketwallet.com/
NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/ , http://3d-id.net/
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including mobile, tech and biometric stocks.
Follow Investorideas.com on Twitter   http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook   http://www.facebook.com/Investorideas
Sign up for our free news alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and use our online stock directories to research stocks – including biometric and mobile payment stocks http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: As of June 2014, NXT-ID renewed for five thousand per month and average of two thousand five hundred 144 shares (cash equivalent) for news publication and marketing of Wocket smart wallet. More info: http://www.investorideas.com/About/Disclaimer.asp   and http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
800-665-0411 -   Source – www.Investorideas.com

Stevia / LOHAS Stock Alert: GLG (TSX: GLG) (OTC: GLGLF) Announces FDA's Issuance of Letter of no Objection for Rebsweet(TM) and AnySweetPLUS(TM) Stevia Extracts

Vancouver, B.C. - June 4, 2014 (Investorideas.com Newswire) GLG Life Tech Corporation (TSX: GLG) (OTC: GLGLF) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality natural sweeteners, announces that the United States Food and Drug Administration ("FDA") has issued a Generally Recognized as Safe ("GRAS") letter of no objection covering several of GLG's high-purity stevia extracts (Filing No. GRN 493). These extracts, each containing over 95% steviol glycosides (predominantly rebaudioside A and stevioside), include GLG's Rebsweet(TM) and AnySweetPLUS(TM) stevia extract products (with rebaudioside A content ranging from 50% to 85%).

The GRAS program is an FDA-approved process that enables companies to conduct independent GRAS determinations through consultations with qualified experts to determine that an ingredient satisfies the FDA's safety criteria. Accordingly, GLG engaged GRAS Associates, LLC, who convened an independent panel of expert scientists to spearhead the safety assessment and compile a dossier describing the months-long study and its results. GLG subsequently submitted that dossier to the FDA for review, resulting in the FDA's letter of no objection.
The latest GRAS designations further GLG's commitment to maintaining the highest quality standards for its products. To date, it has received five GRAS letters of no objection covering an array of high-purity stevia products, with a sixth GRAS determination pending FDA review (for high-purity rebaudioside M) and two other GRAS projects currently underway (for high-purity rebaudioside C and D). Additionally, GLG recently announced its submission of a GRAS notification to the FDA for its Luo Han Guo (Monk Fruit) extract products. GLG has the largest number of stevia products certified under the GRAS process, and remains committed to ensuring that each of its naturally-sourced sweetener products conforms with the GRAS compliance standards.
About GLG Life Tech Corporation
GLG Life Tech Corporation is a global leader in the supply of high purity stevia extracts, an all-natural zero-calorie sweetener used in food and beverages. The Company's vertically integrated operations cover each step in the stevia supply chain including non-GMO stevia seed breeding, natural propagation, stevia leaf growth and harvest, proprietary extraction and refining, marketing and distribution of finished product. For further information, please visit www.glglifetech.com.
Forward-looking statements: This press release contains certain information that may constitute "forward-looking statements" and "forward looking information" (collectively, "forward-looking statements") within the meaning of applicable securities laws. Such forward-looking statements include, without limitation, statements evaluating the market, potential demand for stevia and general economic conditions and discussing future-oriented costs and expenditures. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes" or variations of such words and phrases or words and phrases that state or indicate that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved.
While the Company has based these forward-looking statements on its current expectations about future events, the statements are not guarantees of the Company's future performance and are subject to risks, uncertainties, assumptions and other factors which could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Such factors include amongst others the effects of general economic conditions, consumer demand for our products and new orders from our customers and distributors, changing foreign exchange rates and actions by government authorities, uncertainties associated with legal proceedings and negotiations, industry supply levels, competitive pricing pressures and misjudgments in the course of preparing forward-looking statements. Specific reference is made to the risks set forth under the heading "Risk Factors" in the Company's Annual Information Form for the financial year ended December 31, 2012. In light of these factors, the forward-looking events discussed in this press release might not occur.
Further, although the Company has attempted to identify factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
As there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements, readers should not place undue reliance on forward-looking statements.
Contact:
Stuart Wooldridge, Investor Relations
Phone: +1 (604) 669-2602 ext. 104
Fax: +1 (604) 662-8858
Email: ir@glglifetech.com
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers Disclosure: GLG Life Tech Corporation (TSX: GLG) April 9th 2014 - two months news and content publication , two thousand five hundred per month. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Breaking Tech News: NXT-ID, Inc. (OTCQB: NXTD) Releases Video for Wocket™ Smart Wallet Event Held at the Plaza Hotel; See the First Wocket Public Financial Transaction

SHELTON, Conn. - June 2, 2014 (Investorideas.com Newswire) NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused on the growing mobile, electronic commerce market, today released the video of its first corporate launch event and press conference for its next generation smart wallet, Wocket™, designed to replace all the cards in your wallet. The event was held in New York City on May 28th at the Plaza Hotel from 3:00 p.m. to 5:00 p.m. Attendees included shareholders, Fox News, New York Daily News and other media plus celebrity guest Olivia Culpo, former Miss Universe, Miss USA and Miss Rhode Island.

Mr. Gino Pereira, Chief Executive Officer of NXT-ID said "Meet Wocket, the smartest wallet you will ever own”, providing the audience with compelling reasons why they will want a Wocket smart wallet to address current identity theft and credit card fraud problems.
He told the audience that in the last 18 months there have been over a billion data breaches. When he then turned to the audience to ask who had had their identity or payment information stolen almost half the audience raised their hands.
"A Wocket stores your personal information in a personal vault that is accessed only by you either through your voice or PIN or a customized drawing shape on the screen. It is in there and is safe and secure,” he assured the members of the audience.
He also let the audience know that the Company was pursuing a strategy by which Wocket will become a household name. "Many of you have seen our ads on CNBC and we are following with a very strong digital campaign over the next few months,” he said.
The presentation closed with Wocket making its first public financial transaction.
Following the event consumers could commence ordering the Wocket at http://www.wocketwallet.com/.
See the full video presentation at https://www.youtube.com/watch?v=h2zPNB5i9CA

See Media coverage following the event from Fox News: http://www.myfoxny.com/clip/10209935/smart-wallets
New York Daily News Coverage: http://www.nydailynews.com/new-york/high-tech-wallet-revealed-latest-identity-theft-defense-article-1.1809756
Wocket™ is a smart wallet in the same vein as the smart phone and smart watch. NXT-ID is introducing its innovative, patent-pending Wocket™ as the next natural step in the evolution of smart devices. Wocket™ is a next generation smart wallet designed to replace all the cards in your wallet, with no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.
Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. More than 10,000 cards, records, coupons, etc. and 100 voice commands can also be stored on Wocket™.
The Wocket retails for $149.99.
Advance order a Wocket at: http://www.wocketwallet.com/
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™ ; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.thewocket.com/, http://www.wocketwallet.com/
NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Corporate info: info@nxt-id.com
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
ksmith@proactivecapital.com
Media: 800 665-0411

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: November 2013: Investorideas is compensated by NXTD: five thousand per month for news publication and syndication and is long 144 shares from previous service. More info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

NXT-ID Media Alert: NXT-ID (OTCQB: NXTD) Wocket smart wallet on Fox News May 28th – Live from Plaza event

SHELTON, CT - May 30, 2014 (Investorideas.com Newswire) NXT-ID, Inc., (OTCQB: NXTD), a biometric authentication company focused on the growing m-commerce market, is pleased to announce Fox News’ coverage of the successful launch event for the company’s Wocket™ smart wallet in New York City on May 28th, is now available for viewing at http://www.myfoxny.com/clip/10209935/smart-wallets.

The Fox News, New York affiliate, Fox 5's segment includes commentary by NXT-ID's CEO Gino Pereira along with on-the-street reaction from the public, on the smart-wallet.
Excerpt:
Fox 5 News
"Men have been carrying wallets for ages, which means wallets are ripe for an updating. Companies are competing to turn your wallet into the next high-tech gadget"
"Sometimes smaller is better - and thinner" -Joel Waldman - Fox 5 News
Watch the video in full at http://www.myfoxny.com/clip/10209935/smart-wallets
Wocket™ is a smart wallet in the same vein as the smart phone and smart watch. NXT-ID is introducing its innovative, patent-pending Wocket™ as the next natural step in the evolution of smart devices. Wocket™ is a next generation smart wallet designed to protect your identity and replace all the cards in your wallet, with no smart phone required. The Wocket™ works anywhere credit cards are accepted and only works with your biometric stamp of approval.
Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. More than 10,000 cards, records, coupons, etc. and 100 voice commands can also be stored on Wocket™.
The full Wocket product FAQ is available to consumers and media at   http://nxt-id.com/wocket-faq/
The Wocket™ is now available to order at www.wocketwallet.com . The Wocket™ retail price is $149.99.
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The   company  is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™, a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.   http://www.thewocket.com/
NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com /, http://3d-id.net/
Contacts:
NXT-ID, Inc.
Corporate info: info@nxt-id.com , http://www.nxt-id.com/
About www.InvestorIdeas.com : Big Ideas for global investors
Research Biometrics Stocks at Investorideas.com stock directory
http://www.investorideas.com/BPS/Stock_List.asp
Sign up for free news alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure: This email and content is for subscribers /investors at Investorideas and not for duplication and publication on other websites or blogs. If you would like to publish any content sent from investorideas email please send us a written request. Publication of our email alerts without written permission will be considered a violation of our copyright. The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights.  Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: November 2013: Investorideas is compensated by NXTD: five thousand per month for news publication and syndication and is long 144 shares from previous service. More info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country.